News

Featured

Be Part Of The Answer

SRUK launches first of its kind Raynaud's Citizen Science campaign - calling for 10,000 people to Be Part of The Answer to unlocking progress on Auto-immune conditions affecting millions

Featured

RAIRDA Survey

Have your say on the way your services are working for your Rare Autoimmune Rheumatic Disease (RAIRD)

Featured

Imperial College London's 'Science in Medicine School Teams Prize 2024' now open for entries

The Scleroderma and Raynaud’s UK sponsored 'Science in Medicine School Teams Prize 2024' contest is now open for entries. The contest aims to engage sixth form school students with science in medicine, and challenges students to prepare an ePoster with a novel vision on how to promote the health and well-being of individuals with Scleroderma and/or Raynaud’s. If you're interested in entering, or know someone in sixth form who might be, read on to find out more!

Tuesday 27th February 2018

Nisoldipine significantly reduced the frequency of Raynaud’s attacks in trial

Calcium channel blockers can be used to treat the symptoms of Raynaud’s. A new drug, Nisoldipine, a calcium channel blocker, was tested for the treatment in Raynaud’s in a trial.

Read Article

Saturday 10th February 2018

Statement: Tragic death of Holly Monk

Read Article

Wednesday 7th February 2018

UK Strategy for Rare Diseases (Update)

Read Article

Tuesday 6th February 2018

Rare Disease Day 2018

Rare Disease Day takes place on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients' lives.

Read Article

Friday 2nd February 2018